• Surgical Oncology Insight Banner Ad x

ADVERTISEMENT

Every 10 seconds an article from Annals of Surgical Oncology is downloaded.

HIGHLIGHTED ARTICLES FROM ANNALS OF SURGICAL ONCOLOGY

Weekly Update

Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma

November 26, 2024

Citation: Fogliati, A., Zironda, A., Fiorentini, G. et al. Outcomes of Neoadjuvant Chemotherapy for Invasive Intraductal Papillary Mucinous Neoplasm Compared with de Novo Pancreatic Adenocarcinoma. Ann Surg Oncol 31, 2632–2639 (2024). https://doi.org/10.1245/s10434-023-14875-5

Synopsis:  This retrospective cohort study suggests that invasive Intraductal papillary mucinous cystic neoplasms (IPMN) have a better prognosis when compared to de novo pancreatic ductal adenocarcinoma, and their response to neoadjuvant chemotherapy appears non-inferior.

Robotic Radical Cholecystectomy: Demonstrating Technical Equivalence to Open Surgery in Gallbladder Cancer

November 26, 2024

Citation: Varty, G.P., Patkar, S., Gundavda, K. et al. Robotic Radical Cholecystectomy: Demonstrating Technical Equivalence to Open Surgery in Gallbladder Cancer. Ann Surg Oncol 31, 7896–7897 (2024). https://doi.org/10.1245/s10434-024-15952-z

Synopsis:  This video demonstrates the technical equivalence of the robotic approach when performing portal lymphadenectomy (station 8, 12 and 13) with emphasis on retraction techniques to emulate the open approach.

Listen to the ASO's podcast, Speaking of SurgOnc®

Speaking of SurgOnc Speaking of SurgOnc® is a podcast brought to you by the Annals of Surgical Oncology (ASO) and the Society of Surgical Oncology (SSO).

The series is hosted by ASO Deputy Editor Dr. Frederick L. (Rick) Greene, who expands upon ideas from articles published in the Annals. Once a month, Dr. Greene will interview authors and leading experts in surgical oncology.

Listen to the podcast here.

ASO is the journal of choice of surgical oncologists and cancer multidisciplinary teams worldwide regarding surgical oncology research and education, and benefits surgeons, oncologists, hematologists, radiologists, general practitioners, pathologists, researchers, academicians, and other clinical professionals interested in all aspects of the surgical treatment of cancer. ASO strives to improve the practice environment in which high-quality surgical oncology care is delivered, to enhance the quality of life and survival of the surgical patient with cancer.

Join the conversation! Follow the journal on Twitter and Instagram. Help to expand the reach of the journal to support the research and practice needs of surgical oncologists and their patients.

twitter icon instagram icon

Scroll to Top